Immune Globulin (Human)-ifas (IV) and Lenvatinib Mesylate
Determining the interaction of Immune Globulin (Human)-ifas (IV) and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: immune globulin intravenous
Brand name: Carimune, Flebogamma, Gammaplex, Octagam, Privigen, Panzyga, Gammagard, Gammagard S/D
Synonyms: Immune globulin (intravenous) (IGIV)
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Immune Globulin (Human)-ifas (IV)-Lenvima
- Immune Globulin (Human)-ifas (IV)-Lenvima (14 MG Daily Dose)
- Immune Globulin (Human)-ifas (IV)-Lenvima (18 MG Daily Dose)
- Immune Globulin (Human)-ifas (IV)-Lenvima (20 MG Daily Dose)
- Immune Globulin (Human)-ifas (IV)-Lenvima (24 MG Daily Dose)
- Immune Globulin (Human)-ifas (IV)-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Immune Globulin (Human)-klhw (Subcutaneous)
- Lenvatinib Mesylate-Immune globulin (intramuscular) IGIM
- Lenvatinib Mesylate-Immune globulin (intravenous) IGIV
- Lenvatinib Mesylate-Immune globulin and hyaluronidase Subcutaneous
- Lenvatinib Mesylate-Immune Globulin Injection (IM)
- Lenvatinib Mesylate-Immune Globulin Injection (IV)